跳至主要内容
临床试验/JPRN-UMIN000044249
JPRN-UMIN000044249已完成未知

Multicenter retrospective study of thrombolytic therapy including AT-III for portal vein thrombosis - Efficacy and safety of AT-III for portal vein thrombus

Department of Gastroenterology, Nippon Medecial School0 个研究点目标入组 240 人开始时间: 2021年5月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
240

研究概览

简要总结

This study suggests that maintenance therapy, favorable response, and absence of PVT progression may suppress or control liver-related events in antithrombin III-based therapy for patients with PVT. Specifically, maintenance therapy could suppress not only liver-related events, but also PVT progression and improve the prognosis.

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Department of Gastroenterology, Nippon Medecial School

相似试验